如何引证项目

Feasibility and efficacy of preoperative chemoradiotherapy in patients with locally advanced gastric cancer

   
@article{LCBL5017,
	author = {Yong-Heng  Li 和 Zhong-Wu  Li 和 Shi-Jie Li 和 Lei Tang 和 Shuang- Xi Li 和 Zhao-De Bu 和 Xiao-Fan Li 和 Zi-Yu  Li 和 Jia-Fu  Ji},
	title = {Feasibility and efficacy of preoperative chemoradiotherapy in patients with locally advanced gastric cancer},
	journal = {临床与病理杂志},
	volume = {35},
	number = {1},
	year = {2024},
	keywords = {},
	abstract = {Objective: Investigate the feasibility and efficacy of neoadjuvant chemoradiotherapy for locally advanced gastric cancer. Methods: Intensity-modulated radiotherapy (IMRT), with 50/45 Gy in 25 fractions. The concurrent chemotherapy regimens included oral TS-1 plus oxaliplatin 40 mg/m2 intravenously weekly (10 patients) or TS-1 alone (120 mg/day, 25 patients). Surgical resection was performed within 6~8 weeks after the last day of radiotherapy. Results:No grade 4 toxicity recorded. The incidence of grade 3 toxicity is 11.4%: thrombocytopenia (5.7%), neutropenia (2.9%) and radiation esophagitis (2.9%). Pathological complete response 8.6% (3/35).Surgery-related complications consisted of anastomotic leakage in 2 patients (7.1%), infection in 3 (10.7%) and hemorrhage in 2 (7.1%). No postoperative mortality was recorded. The 1-year and 2-year overall survival (OS) rates were 88.3% and 59.6%respectively. Conclusion: In this study, neoadjuvant chemoradiotherapy showed an acceptable toxicity and promising efficacy in patients with locally advanced gastric cancer. },
	url = {https://lcbl.amegroups.com/article/view/5017}
}